CLINICAL_TRIALS
trial_result
· 2007-11-26
Clinical Trial Update: 20 Week Bridging Study in Type II DM [Phase 3]
Summary
The document reports completion of a 20-week bridging Phase 3 trial in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus Type II | Phase 3 | Status: COMPLETED